We are are pleased to announce that as of April 2025, our company has entered a new investors’ scheme. This strategic development marks an exciting milestone in our growth journey, reinforcing our commitment to innovation, quality and customer-focused solutions in the CDMO industry.
With strengthened resources and a shared vision for the future, Labomed SA is poised to accelerate its expansion and continue to deliver services of exceptional quality to its partners and customers worldwide.
